Shareholders Equity: The sum of preferred and common equity items.
Pulse Biosciences, Inc (PLSE) had Shareholders Equity of $66.30M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.40M |
|
$-18.58M |
|
$0.37M |
|
$0.03M |
|
$19.55M |
|
$-19.15M |
|
$0.57M |
|
$-18.58M |
|
$-18.58M |
|
$-18.58M |
|
$-18.58M |
|
$-18.58M |
|
$-18.58M |
|
$-19.15M |
|
$-18.89M |
|
67.99M |
|
67.99M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$71.13M |
|
$1.02M |
|
$10.49M |
|
$81.62M |
|
$9.80M |
|
-- |
|
$5.53M |
|
$15.32M |
|
$66.30M |
|
$63.10M |
|
|
Shareholders Equity |
$66.30M |
67.84M |
|
| Cash Flow Statement Financials | |
$-14.60M |
|
$-0.03M |
|
$2.21M |
|
$80.73M |
|
$68.32M |
|
$-12.42M |
|
$1.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
7.73% |
|
-4775.56% |
|
-4775.56% |
|
-- |
|
-4633.67% |
|
-4633.67% |
|
$-14.63M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
1.80 |
|
2.55 |
|
35.24 |
|
-28.03% |
|
-29.45% |
|
-22.76% |
|
-28.03% |
|
$0.98 |
|
$-0.22 |
|
$-0.21 |
|